Zemaira 57516-0101
Generic: Alpha-1-Proteinase Inhibitor Human Kit
Product NDC
57516-0101- Manufacturer
- Fisher Clinical Services Inc.
- Dosage Form
- Kit
- Route
- Intravenous
- Product Type
- Plasma Derivative
- Marketing Start
- February 22, 2022
- Listing Expires
- December 31, 2026
- Application
- BLA125078
Packaging Options(1)
1 KIT in 1 CARTON (57516-101-02) * 20 mL in 1 VIAL, SINGLE-DOSE (57516-102-01) * 20 mL in 1 VIAL, SINGLE-DOSE (57516-103-20)